Flow cytometry drives pharma by enabling immunophenotyping, biomarker discovery, clinical trials, and cell therapy. This blog explores how data quality, education, and standardization turn cytometry into a strategic decision-making tool.
SuperNova Flow Cytometry is an independent educational provider with no affiliation, endorsement, sponsorship, and/or connection to Beckman Coulter, Inc. or Beckman Coulter, Inc.’s SUPERNOVA flow cytometry products.